Literature DB >> 6429699

Effects of ascorbate on a dopaminergic response: apomorphine-induced modification of pentylenetetrazol-induced seizures in mice.

R E Wilcox, W H Riffee, C P Goldman, R K Young.   

Abstract

The threshold for pentylenetetrazol (PTZ)-induced clonic seizures is below control levels 15 min after administration of apomorphine (APO) but above them 60 min after APO administration. Pretreatment with ascorbic acid (10 mg/kg) or the presence of ascorbic acid in the APO solution (1 mg/ml) inhibited the early (15 min) decrease in seizure threshold caused by 60 mg/kg APO and reversed the increase in seizure threshold 60 min after a 50 mg/kg APO challenge. Ascorbate co-administration concomitant with APO also counteracted the increase in seizure threshold 60 min after 70/kg APO. Results suggest a potential model for modulation of a seizure system through dietary supplementation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429699     DOI: 10.1007/bf00427421

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice.

Authors:  W H Riffee; M C Gerald
Journal:  Neuropharmacology       Date:  1976-11       Impact factor: 5.250

2.  Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio papio.

Authors:  B Meldrum; G Anlezark; M Trimble
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

3.  Neurophysiology of photically induced epilepsy in Papio papio.

Authors:  R Naquet; J Catier; C Menini
Journal:  Adv Neurol       Date:  1975

4.  Timed intravenous infusion of metrazol and strychnine for testing anticonvulsant drugs.

Authors:  M J ORLOFF; H L WILLIAMS; C C PFEIFFER
Journal:  Proc Soc Exp Biol Med       Date:  1949-02

5.  Antiepileptic drug development: I. History and a program for progress.

Authors:  R L Krall; J K Penry; H J Kupferberg; E A Swinyard
Journal:  Epilepsia       Date:  1978-08       Impact factor: 5.864

6.  Acute and chronic effects of (-)-amphetamine on seizure threshold and brain catecholamines in mice.

Authors:  W H Riffee; M C Gerald
Journal:  Biochem Pharmacol       Date:  1977-04-15       Impact factor: 5.858

7.  Antiepileptic drug development: II. Anticonvulsant drug screening.

Authors:  R L Krall; J K Penry; B G White; H J Kupferberg; E A Swinyard
Journal:  Epilepsia       Date:  1978-08       Impact factor: 5.864

8.  Inhibition of reflex epilepsy by (+/-)-N-n-propylnorapomorphine.

Authors:  C Ashton; G Anlezark; B Meldrum
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432

9.  Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine-receptor agonist.

Authors:  L F Quesney; F Andermann; S Lal; S Prelevic
Journal:  Neurology       Date:  1980-11       Impact factor: 9.910

10.  Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.

Authors:  W H Riffee; R E Wilcox; C P Goldman; R V Smith
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  2 in total

1.  Experimental catalepsy is both enhanced and disrupted by apomorphine.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 2.  Nutritional Aspects of Treatment in Epileptic Patients.

Authors:  Danesh Soltani; Majid Ghaffar Pour; Abbas Tafakhori; Payam Sarraf; Sama Bitarafan
Journal:  Iran J Child Neurol       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.